Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Cancer Res. 2013 Jan 30;73(7):2127–2138. doi: 10.1158/0008-5472.CAN-12-4184

Table 1.

CD20loCD19+ B cells from B-CLL patients suppress T cells

Patients Compared to ND Rituximab
CD20 decrease * Suppression 4-1BBL
1 + +++ Low +
− − Low −
2 − − ND −
− − ND −
3 + +++ Low +
4 + ++ Low −
5 + ++ Low −
6 + ++ Equal +
7 + + ND +
8 + + High −
9 − − Equal −
10 − − High −
11 − − Equal −
12 − + Low +
13 + ++ low +

CD19+ B cells from B-CLL patients were phenotyped for CD20 and 4-1BBL expression and tested for T cell suppression

*

+ corresponds to > 40% decrease compared to ND